Skip to content

A randomized controlled trial of fenofibrate on prediabetes with hypertriglyceridemia.

A randomized controlled trial for investigating the protective effects of fenofibrate on prediabetes with hypertriglyceridemia.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000548
Enrollment
Unknown
Registered
2009-10-05
Start date
2006-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes

Interventions

Group A:metformin, 500mg, t.i.d.
Group B:fenofibrate 200mg once a day
Group C:detailed diet recommendation

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis was prediabetes; 2. Male and female aged of 18 to 75 years old; 3. Body-mass index of 24 or higher; 4. Wrist circumference of 85cm or higher for male, and 80cm or higher for female; 5. Plasma triglyceride levels of 1.7 mmol per liter or higher.

Exclusion criteria

Exclusion criteria: 1. Diagnosis was diabetes mellitus; 2. Taking medicines known to influence glucose or lipid metabolism; 3. Presence of chronic liver disease, gastrointestinal disease and other illnesses known to alter glucose tolerance; 4. Presence of other psychological or physical disabilities deemed likely to reduce their life expectancy or their ability to participate in the trial.

Design outcomes

Primary

MeasureTime frame
plasma lipid levels;75g oral glucose tloerance test;plasma insulin level;

Secondary

MeasureTime frame
body weight;wrist circumference;biochemical indices of liver function;Body-mass index;

Countries

China

Contacts

Public ContactJiajun Zhao
jjzhao@medmail.com.cn+86 13708932909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026